We are a NIAID funded Clinical Research Site (The Miriam Hospital, Site 2951) of the Harvard/Boston/Providence Clinical Trial Unit (PIs Dolin, Kuritzkes, Mayer, Grant # AI069412). Dr. Karen Tashima is the CRS Site Leader of The Miriam Hospital site. The other two sites are MGH and Brigham and Women’s Hospital.
The mission of the AIDS Clinical Trials Group (ACTG) Network is to cure HIV and reduce the burden of disease due to HIV infection and its complications, including tuberculosis and viral hepatitis.
The public website is www.actgnetwork.orgÂ
Our site investigators are Drs. Martha Sanchez, Tara Bouton, Susan Cu-Uvin, Natasha Rybak and Karen Tashima (CRS Leader). Our investigators and staff guide the overall ACTG scientific clinical trials agenda by participating in committees and study teams to address tuberculosis, women’s health, neurology, and antiretroviral therapy strategies such as the long-acting injectable medications.
The Miriam Hospital has been an active ACTG site since 2000.
Active HIV Clinical Trials
| Providence | |
| Boston |